(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Nautilus Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NAUT's revenue for 2024 to be $472,745,644, with the lowest NAUT revenue forecast at $472,745,644, and the highest NAUT revenue forecast at $472,745,644. On average, 2 Wall Street analysts forecast NAUT's revenue for 2025 to be $1,212,075,297, with the lowest NAUT revenue forecast at $472,745,644, and the highest NAUT revenue forecast at $1,951,530,048.
In 2026, NAUT is forecast to generate $3,408,797,582 in revenue, with the lowest revenue forecast at $3,408,797,582 and the highest revenue forecast at $3,408,797,582.